IDENTIFICATION OF PUTATIVE PROTEIN CANDIDATES IN THE EXPORT MECHANISM OF ANNEXI
附件出口机制中推定候选蛋白质的鉴定
基本信息
- 批准号:7722216
- 负责人:
- 金额:$ 0.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-03-01 至 2009-02-28
- 项目状态:已结题
- 来源:
- 关键词:Acute Promyelocytic LeukemiaAlteplaseAnnexinsBiological AssayBlood VesselsCell DeathCell membraneCell surfaceCellsComputer Retrieval of Information on Scientific Projects DatabaseCytolysisCytoplasmDisease susceptibilityEndothelial CellsFibrinFundingGenerationsGrantHemorrhageIn VitroInjuryInstitutionMass Spectrum AnalysisMessenger RNAMusMutationPathway interactionsPeptide Signal SequencesPlasminPlasminogenProtein SecretionProtein Tyrosine KinaseProteinsResearchResearch PersonnelResourcesS100 family protein p11SourceStressStress-Induced ProteinTemperatureThrombusTyrosineTyrosine PhosphorylationUnited States National Institutes of Healthhuman subjectin vivonovelplasminogen receptorprotein expressionresponse
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Annexin 2 is a profibrinolytic co-receptor for plasminogen and tissue plasminogen activator that stimulates activation of the major fibrinolysin, plasmin, at cell surfaces. In human subjects, over-expression of annexin 2 in acute promyelocytic leukemia leads to a bleeding diathesis reflective of excessive cell surface annexin 2-dependent generation of plasmin. In addition, mice completely deficient in annexin 2 display fibrin accumulation within blood vessels and impaired clearance of injury-induced thrombi. We have previously shown that endothelial cell annexin 2, a protein that lacks a typical signal peptide, translocates from the cytoplasm to the extracytoplasmic plasma membrane in response to brief temperature stress both in vitro and in vivo in the absence of cell death or cell lysis. This regulated response is independent of new protein or mRNA synthesis and does not require the classical endoplasmic reticulumGolgi pathway. Translocation of annexin 2 induced by temperature stress is dependent on both expression of protein p11 (S100A10) and tyrosine phosphorylation of annexin 2 because the release of annexin 2 is completely eliminated on depletion of p11, inactivation of tyrosine kinase, or mutation of tyrosine 23. Translocation of annexin 2 to the cell surface dramatically increases tissue plasminogen activator-dependent plasminogen activation potential and may represent a novel stress-induced protein secretion pathway. We have identified by immunoaffinity assays and mass spectrometry at least four proteins that may be associated with the translocation mechanism of annexin 2 to the cell surface. These putative protein candidates are currently being investigated.
该子项目是利用该技术的众多研究子项目之一
资源由 NIH/NCRR 资助的中心拨款提供。子项目和
研究者 (PI) 可能已从 NIH 的另一个来源获得主要资金,
因此可以在其他 CRISP 条目中表示。列出的机构是
对于中心来说,它不一定是研究者的机构。
膜联蛋白 2 是纤溶酶原和组织纤溶酶原激活剂的纤溶原共受体,可刺激细胞表面主要纤溶酶(纤溶酶)的激活。在人类受试者中,急性早幼粒细胞白血病中膜联蛋白 2 的过度表达会导致出血素质,这反映了细胞表面膜联蛋白 2 依赖性纤溶酶的过度生成。此外,完全缺乏膜联蛋白2的小鼠表现出血管内的纤维蛋白积聚以及损伤引起的血栓的清除受损。我们之前已经证明,在没有细胞死亡或细胞裂解的情况下,内皮细胞膜联蛋白 2(一种缺乏典型信号肽的蛋白质)在体外和体内响应短暂的温度应激,从细胞质易位到胞质外质膜。这种调节反应独立于新蛋白质或 mRNA 合成,并且不需要经典的内质网高尔基体途径。温度应激诱导的膜联蛋白 2 易位取决于蛋白 p11 (S100A10) 的表达和膜联蛋白 2 的酪氨酸磷酸化,因为膜联蛋白 2 的释放在 p11 耗尽、酪氨酸激酶失活或酪氨酸 23 突变时完全消除。膜联蛋白 2 易位到细胞表面会显着增加组织纤溶酶原激活剂依赖性纤溶酶原 激活潜力,可能代表一种新的应激诱导的蛋白质分泌途径。我们通过免疫亲和测定和质谱鉴定了至少四种可能与膜联蛋白 2 向细胞表面易位机制相关的蛋白质。目前正在研究这些假定的候选蛋白质。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KATHERINE AMBERSON HAJJAR其他文献
KATHERINE AMBERSON HAJJAR的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KATHERINE AMBERSON HAJJAR', 18)}}的其他基金
IDENTIFICATION OF PUTATIVE UBIQUINATION SITES ON CALPACTIN
钙肽酶上假定的泛化位点的鉴定
- 批准号:
7722228 - 财政年份:2008
- 资助金额:
$ 0.11万 - 项目类别:
IDENTIFICATION OF PUTATIVE UBIQUINATION SITES ON CALPACTIN
钙肽酶上假定的泛化位点的鉴定
- 批准号:
7355121 - 财政年份:2006
- 资助金额:
$ 0.11万 - 项目类别:
IDENTIFICATION OF PUTATIVE PROTEIN CANDIDATES IN THE EXPORT MECHANISM OF ANNEXI
附件出口机制中推定候选蛋白质的鉴定
- 批准号:
7355101 - 财政年份:2006
- 资助金额:
$ 0.11万 - 项目类别:
Multidisciplinary Vascular Surgery Research Training Program
多学科血管外科研究培训计划
- 批准号:
7406016 - 财政年份:2006
- 资助金额:
$ 0.11万 - 项目类别:
The Annexin 2 Stress Response in Vascular Cells
血管细胞中的膜联蛋白 2 应激反应
- 批准号:
7218204 - 财政年份:2006
- 资助金额:
$ 0.11万 - 项目类别:
IDENTIFICATION OF PUTATIVE UBIQUINATION SITES ON CALPACTIN
钙肽酶上假定的泛化位点的鉴定
- 批准号:
7180028 - 财政年份:2005
- 资助金额:
$ 0.11万 - 项目类别:
IDENTIFICATION OF PUTATIVE PROTEIN CANDIDATES IN THE EXPORT MECHANISM OF ANNEXIN
Annexin 出口机制中推定候选蛋白质的鉴定
- 批准号:
7180008 - 财政年份:2005
- 资助金额:
$ 0.11万 - 项目类别:
相似海外基金
AcT-Cog: Online cognitive assessment in the Alteplase compared to Tenecteplase (AcT) trial.
AcT-Cog:阿替普酶与替奈普酶 (AcT) 试验相比的在线认知评估。
- 批准号:
444794 - 财政年份:2021
- 资助金额:
$ 0.11万 - 项目类别:
Operating Grants
INTERRAcT: Thrombus characteristics for predicting Reperfusion with Alteplase compared to Tenecteplase
INTERRAcT:与替奈普酶相比,阿替普酶预测再灌注的血栓特征
- 批准号:
433102 - 财政年份:2020
- 资助金额:
$ 0.11万 - 项目类别:
Operating Grants
Alteplase Compared to Tenecteplase in patients with Acute Ischemic Stroke: QuICR & OPTIMISE Registry based Pragmatic Randomized Controlled Trial
阿替普酶与替奈普酶治疗急性缺血性中风患者的比较:QuICR
- 批准号:
401715 - 财政年份:2019
- 资助金额:
$ 0.11万 - 项目类别:
Operating Grants
Tenecteplase versus Alteplase for Stroke Thrombolysis Evaluation (TASTE) Trial
替奈普酶与阿替普酶用于中风溶栓评估 (TASTE) 试验
- 批准号:
nhmrc : 1079696 - 财政年份:2015
- 资助金额:
$ 0.11万 - 项目类别:
Project Grants
Tenecteplase versus Alteplase for Stroke Thrombolysis Evaluation (TASTE) Trial
替奈普酶与阿替普酶用于中风溶栓评估 (TASTE) 试验
- 批准号:
nhmrc : GNT1079696 - 财政年份:2015
- 资助金额:
$ 0.11万 - 项目类别:
Project Grants
Low-Dose Tenecteplase vs Standard-Dose Alteplase for Acute Ischaemic Stroke: An Imaging Based Safety and Efficacy Study
低剂量替奈普酶与标准剂量阿替普酶治疗急性缺血性中风:一项基于影像学的安全性和有效性研究
- 批准号:
nhmrc : 510722 - 财政年份:2008
- 资助金额:
$ 0.11万 - 项目类别:
NHMRC Project Grants
Treatment of Deep Vein Thrombosis of the Lower Extremities w/Low Dose Alteplase
小剂量阿替普酶治疗下肢深静脉血栓
- 批准号:
8565339 - 财政年份:
- 资助金额:
$ 0.11万 - 项目类别:
Treament of Deep Vein Thrombosis of the Lower Extremities w/Low Dose Alteplase
小剂量阿替普酶治疗下肢深静脉血栓
- 批准号:
7593114 - 财政年份:
- 资助金额:
$ 0.11万 - 项目类别:
Treatment of Deep Vein Thrombosis of the Lower Extremities w/Low Dose Alteplase
小剂量阿替普酶治疗下肢深静脉血栓
- 批准号:
8952839 - 财政年份:
- 资助金额:
$ 0.11万 - 项目类别:














{{item.name}}会员




